EGO PHARMACEUTICALS (UK) LIMITED
Get an alert when EGO PHARMACEUTICALS (UK) LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-03-31 (in 10mo)
Last filed for 2025-06-30
Confirmation statement due
2027-02-08 (in 9mo)
Last made up 2026-01-25
Watchouts
None on the register
Cash
£288K
-53% vs 2024
Net assets
£745K
+48.5% vs 2024
Employees
35
+2.9% vs 2024
Profit before tax
£325K
+102.8% vs 2024
Name history
Renamed 1 time since incorporation
- EGO PHARMACEUTICALS (UK) LIMITED 2002-02-14 → present
- TIBRO5 LIMITED 2002-01-11 → 2002-02-14
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · latest reflected 2025-06-30
| Metric | Trend | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Turnover | £11,423,343 | £7,451,574 | |
| Operating profit | £160,082 | £324,580 | |
| Profit before tax | £160,082 | £324,580 | |
| Net profit | £120,017 | £243,435 | |
| Cash | £613,889 | £288,340 | |
| Total assets less current liabilities | £511,546 | £754,981 | |
| Net assets | £501,884 | £745,319 | |
| Equity | £501,884 | £745,319 | |
| Average employees | 34 | 35 | |
| Wages | £1,736,364 | £1,995,700 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-06-30 | 2025-06-30 |
|---|---|---|---|
| Operating margin | 1.4% | 4.4% | |
| Net margin | 1.1% | 3.3% | |
| Return on capital employed | 31.3% | 43.0% | |
| Gearing (liabilities / total assets) | 93.2% | 87.1% | |
| Current ratio | 1.07x | 1.15x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- Grant Thornton
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“As at 30 June 2025, the company has net current assets of £730,163 and has received a letter of continued financial support from its immediate parent entity, Ego Pharmaceuticals Holdings Pty Ltd. Based on the above, the directors believe that the going concern basis is appropriate.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 5 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OPPENHEIM, Alan | Secretary | 2002-02-20 | — | Australian |
| OPPENHEIM, Alan | Director | 2002-02-20 | Dec 1957 | Australian |
| OPPENHEIM, Victoria Marie Jane | Director | 2002-02-20 | Jan 1959 | Australian |
Show 5 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| CARTER, Hayley | Secretary | 2006-01-30 | 2010-07-01 |
| CLARKE, Erica Louise | Secretary | 2002-01-11 | 2002-02-20 |
| DAVIES, Sally Anne | Secretary | 2003-10-30 | 2006-01-30 |
| CLARKE, Erica Louise | Director | 2002-01-11 | 2002-02-20 |
| DAVIES, Sally Anne | Director | 2002-01-11 | 2002-02-20 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 80 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-03-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-01 | AA | accounts | Accounts with accounts type full | |
| 2025-02-28 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-12-24 | AA | accounts | Accounts with accounts type small | |
| 2024-02-19 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-01-19 | AA | accounts | Accounts with accounts type small | |
| 2023-01-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-12-14 | AA | accounts | Accounts with accounts type small | |
| 2022-02-28 | AA | accounts | Accounts with accounts type small | |
| 2022-02-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-10-20 | AD01 | address | Change registered office address company with date old address new address | |
| 2021-01-25 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-01-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-11-06 | AA | accounts | Accounts with accounts type small | |
| 2020-02-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2019-11-21 | AA | accounts | Accounts with accounts type small | |
| 2019-02-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2018-11-15 | AA | accounts | Accounts with accounts type small | |
| 2018-01-29 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2017-10-23 | AA | accounts | Accounts with accounts type small |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-06-30 vs 2024-06-30
-
Turnover
-34.8%
£11,423,343 £7,451,574
-
Cash
-53%
£613,889 £288,340
-
Net assets
+48.5%
£501,884 £745,319
-
Employees
+2.9%
34 35
-
Operating profit
+102.8%
£160,082 £324,580
-
Profit before tax
+102.8%
£160,082 £324,580
-
Wages
+14.9%
£1,736,364 £1,995,700
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers